These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

321 related items for PubMed ID: 2390486

  • 21. Mitomycin C sensitivity in human bladder cancer cells: possible role of glutathione and glutathione transferase in resistance.
    Xu BH, Gupta V, Singh SV.
    Arch Biochem Biophys; 1994 Jan; 308(1):164-70. PubMed ID: 8311448
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Combined in vitro modulation of adriamycin resistance.
    Meijer C, Mulder NH, Timmer-Bosscha H, Peters WH, de Vries EG.
    Int J Cancer; 1991 Oct 21; 49(4):582-6. PubMed ID: 1680815
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Nitrogen mustard-DNA interaction in melphalan-resistant mammary carcinoma cells with elevated intracellular glutathione and glutathione-S-transferase activity.
    Alaoui-Jamali MA, Panasci L, Centurioni GM, Schecter R, Lehnert S, Batist G.
    Cancer Chemother Pharmacol; 1992 Oct 21; 30(5):341-7. PubMed ID: 1505071
    [Abstract] [Full Text] [Related]

  • 27. Inhibition of radiation-induced DNA-protein cross-link repair by glutathione depletion with L-buthionine sulfoximine.
    Oleinick NL, Xue LY, Friedman LR, Donahue LL, Biaglow JE.
    NCI Monogr; 1988 Oct 21; (6):225-9. PubMed ID: 3352769
    [Abstract] [Full Text] [Related]

  • 28. Role of glutathione in the in vitro synergism between 4-hydroperoxy-cyclophosphamide and cisplatin in leukemia cell lines.
    Peters RH, Jollow DJ, Stuart RK.
    Cancer Res; 1991 May 15; 51(10):2536-41. PubMed ID: 2021933
    [Abstract] [Full Text] [Related]

  • 29. Enhanced DNA repair and tolerance of DNA damage associated with resistance to cis-diammine-dichloroplatinum (II) after in vitro exposure of a human teratoma cell line to fractionated X-irradiation.
    Hill BT, Shellard SA, Hosking LK, Fichtinger-Schepman AM, Bedford P.
    Int J Radiat Oncol Biol Phys; 1990 Jul 15; 19(1):75-83. PubMed ID: 2380098
    [Abstract] [Full Text] [Related]

  • 30. Glutathione depletion by DL-buthionine-SR-sulfoximine (BSO) potentiates X-ray-induced chromosome lesions after liquid holding recovery.
    Bertsche U, Schorn H.
    Radiat Res; 1986 Mar 15; 105(3):351-69. PubMed ID: 3754339
    [Abstract] [Full Text] [Related]

  • 31. Effect of glutathione depletion on the cytotoxicity of cisplatin and iproplatin in a human melanoma cell line.
    Pendyala L, Perez R, Weinstein A, Zdanowicz J, Creaven PJ.
    Cancer Chemother Pharmacol; 1997 Mar 15; 40(1):38-44. PubMed ID: 9137527
    [Abstract] [Full Text] [Related]

  • 32. Depletion of glutathione after gamma irradiation modifies survival.
    Saunders EL, Meredith MJ, Eisert DR, Freeman ML.
    Radiat Res; 1991 Mar 15; 125(3):267-76. PubMed ID: 2000450
    [Abstract] [Full Text] [Related]

  • 33. Glutathione depletion and cytotoxicity of buthionine sulphoximine and SR2508 in rodent and human cells.
    Ling CC, Wong RS, Basas RD.
    Int J Radiat Oncol Biol Phys; 1990 Feb 15; 18(2):325-30. PubMed ID: 2137437
    [Abstract] [Full Text] [Related]

  • 34. Modulation by D,L-buthionine-S,R-sulphoximine of etoposide cytotoxicity on human non-small cell lung, ovarian and breast carcinoma cell lines.
    Mans DR, Schuurhuis GJ, Treskes M, Lafleur MV, Retèl J, Pinedo HM, Lankelma J.
    Eur J Cancer; 1992 Feb 15; 28A(8-9):1447-52. PubMed ID: 1325177
    [Abstract] [Full Text] [Related]

  • 35. Involvement of intracellular glutathione in induction of apoptosis by cisplatin in a human pharyngeal carcinoma cell line.
    Sugimoto C, Matsukawa S, Fujieda S, Noda I, Tanaka N, Tsuzuki H, Saito H.
    Anticancer Res; 1996 Feb 15; 16(2):675-80. PubMed ID: 8687113
    [Abstract] [Full Text] [Related]

  • 36. Multifactorial mechanisms associated with broad cross-resistance of ovarian carcinoma cells selected by cyanomorpholino doxorubicin.
    Lau DH, Lewis AD, Ehsan MN, Sikic BI.
    Cancer Res; 1991 Oct 01; 51(19):5181-7. PubMed ID: 1717140
    [Abstract] [Full Text] [Related]

  • 37. Effect of glutathione on DNA repair in cisplatin-resistant human ovarian cancer cell lines.
    Lai GM, Ozols RF, Young RC, Hamilton TC.
    J Natl Cancer Inst; 1989 Apr 05; 81(7):535-9. PubMed ID: 2493524
    [Abstract] [Full Text] [Related]

  • 38. Expression of apoptosis-related proteins and morphological changes in a rat tumor model of human small cell lung cancer prior to and after treatment with radiotherapy, carboplatin, or combined treatment.
    Fokkema E, De Vries EG, Groen HJ, Meijer C, Timens W.
    Virchows Arch; 2003 Apr 05; 442(4):349-55. PubMed ID: 12715170
    [Abstract] [Full Text] [Related]

  • 39. Human larynx carcinoma cells resistant to cis-diamminedichloroplatinum(II): mechanisms involved in the resistance.
    Beketić-Oresković L, Osmak M, Jaksić M.
    Neoplasma; 1994 Apr 05; 41(3):163-9. PubMed ID: 7935985
    [Abstract] [Full Text] [Related]

  • 40. Resistance of human cervical carcinoma cells to tumor necrosis factor correlates with their increased sensitivity to cisplatin: evidence of a role for DNA repair and epidermal growth factor receptor.
    Nishikawa K, Rosenblum MG, Newman RA, Pandita TK, Hittelman WN, Donato NJ.
    Cancer Res; 1992 Sep 01; 52(17):4758-65. PubMed ID: 1380890
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.